Related references
Note: Only part of the references are listed.Design, Synthesis, and Characterization of the Macrocyclic Tetrapeptide cyclo[Pro-Sar-Phe-D-Phe]: A Mixed Opioid Receptor Agonist-Antagonist Following Oral Administration
Michael J. Ferracane et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Multifunctional opioid receptor agonism and antagonism by a novel macrocyclic tetrapeptide prevents reinstatement of morphine-seeking behaviour
Ariana C. Brice-Tutt et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Endogenous and Exogenous Opioids in Pain
Gregory Corder et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 41 (2018)
In vivo effects of -opioid receptor agonist/δ-opioid receptor antagonist peptidomimetics following acute and repeated administration
Jessica P. Anand et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Selective κ receptor partial agonist HS666 produces potent antinociception without inducing aversion after i.c.v. administration in mice
Mariana Spetea et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Development of a robust, sensitive and selective liquid chromatography-tandem mass spectrometry assay for the quantification of the novel macrocyclic peptide kappa opioid receptor antagonist [D-Trp]CJ-15,208 in plasma and application to an initial pharmacokinetic study
Tanvir Khaliq et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2016)
Opioid Abuse in Chronic Pain - Misconceptions and Mitigation Strategies
Nora D. Volkow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The mixed-action delta/mu opioid agonist MMP-2200 does not produce conditioned place preference but does maintain drug self-administration in rats, and induces in vitro markers of tolerance and dependence
Glenn W. Stevenson et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2015)
Alanine analogues of [D-Trp]CJ-15,208: novel opioid activity profiles and prevention of drug- and stress-induced reinstatement of cocaine-seeking behaviour
J. V. Aldrich et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Inhibition of Gβγ-subunit signaling potentiates morphine-induced antinociception but not respiratory depression, constipation, locomotion, and reward
Michelle R. Hoot et al.
BEHAVIOURAL PHARMACOLOGY (2013)
The macrocyclic tetrapeptide [D-Trp]CJ-15,208 produces short-acting κ opioid receptor antagonism in the CNS after oral administration
Shainnel O. Eans et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
The Macrocyclic Peptide Natural Product CJ-15,208 Is Orally Active and Prevents Reinstatement of Extinguished Cocaine-Seeking Behavior
Jane V. Aldrich et al.
JOURNAL OF NATURAL PRODUCTS (2013)
Novel opioid cyclic tetrapeptides: Trp isomers of CJ-15,208 exhibit distinct opioid receptor agonism and short-acting κ opioid receptor antagonism
Nicolette C. Ross et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Unexpected Opioid Activity Profiles of Analogues of the Novel Peptide Kappa Opioid Receptor Ligand CJ-15,208
Jane V. Aldrich et al.
CHEMMEDCHEM (2011)
Guidelines for reporting experiments involving animals: the ARRIVE guidelines
J. C. McGrath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Bi- or multifunctional opioid peptide drugs
Peter W. Schiller
LIFE SCIENCES (2010)
Synthesis of CJ-15,208, a novel κ-opioid receptor antagonist
Nicolette C. Ross et al.
TETRAHEDRON LETTERS (2010)
Nascent structure-activity relationship study of a diastereomeric series of kappa opioid receptor antagonists derived from CJ-15,208
Roland E. Dolle et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Effects of Atypical kappa-Opioid Receptor Agonists on Intrathecal Morphine-Induced Itch and Analgesia in Primates
Mei-Chuan Ko et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Mu/Kappa Opioid Interactions in Rhesus Monkeys: Implications for Analgesia and Abuse Liability
S. Stevens Negus et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2008)
A Novel Gβγ-Subunit Inhibitor Selectively Modulates μ-Opioid-Dependent Antinociception and Attenuates Acute Morphine-Induced Antinociceptive Tolerance and Dependence
Jennifer L. Mathews et al.
JOURNAL OF NEUROSCIENCE (2008)
Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opiold receptor antagonist pharmacophores
Natalie R. Lenard et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
The convulsive and electroencephalographic changes produced by nonpeptidic δ-opioid agonists in rats:: Comparison with pentylenetetrazol
Emily M. Jutkiewicz et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
A bivalent ligand (KDAN-18) containing δ-antagonist and k-agonist pharmacophores bridges δ2 and k1 opioid receptor phenotypes
DJ Daniels et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Opioid interactions in rhesus monkeys: Effects of delta plus mu and delta plus kappa agonists on schedule-controlled responding and thermal nociception
GW Stevenson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
CJ-15,208, a novel kappa opioid receptor antagonist from a fungus, Ctenomyces serratus ATCC15502
T Saito et al.
JOURNAL OF ANTIBIOTICS (2002)
Share Paper
